Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹10.65
Market cap
₹238.8 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-1.0×Sector 47.4×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

23:40 IST BSE
Merger & Restructuring

Nectar Lifesciences Merger & Restructuring Worth ₹11.22 Cr

Nectar Lifesciences sold its non-core unit, Narbada Industries, including land leasehold rights and machinery, to Shree Balaji Cold Chain & Storage Services for ₹11.22 Crore.

Value
₹11.22 Cr
17:09 IST BSE
Merger & Restructuring

Nectar Lifesciences Merger & Restructuring

Nectar Lifesciences extended the expected completion date for the slump sale of its Empty Hard Gelatin Capsule business to Capnest Health Care to December 31, 2026.

16:29 IST NSE
Merger & Restructuring

Nectar Lifesciences Merger & Restructuring

Nectar Lifesciences Limited has extended the completion date for the slump sale of its Empty Hard Gelatin Capsule business to Capnest Health Care Private Limited. The parties mutually agreed to extend the expected closing to July 31, 2026. Other transaction terms remain unchanged from the previous disclosure dated December 20, 2025.

Execution
on or before July 31, 2026